Molecular Diagnostics Market Size, Share, and Trends 2024 to 2034

The global molecular diagnostics market size is estimated at USD 45.11 billion in 2025 and is forecasted to worth around USD 63.86 billion by 2034, accelerating at a CAGR of 3.87% from 2025 to 2034. The North America molecular diagnostics market size crossed USD 17.47 billion in 2024 and is expanding at a CAGR of 3.90% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 2257
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Molecular Diagnostics Market 

5.1. COVID-19 Landscape: Molecular Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Molecular Diagnostics Market, By Product

8.1. Molecular Diagnostics Market, by Product

8.1.1. Instruments

8.1.1.1. Market Revenue and Forecast

8.1.2. Reagents

8.1.2.1. Market Revenue and Forecast

8.1.3. Services & Software

8.1.3.1. Market Revenue and Forecast

Chapter 9. Global Molecular Diagnostics Market, By Test Location

9.1. Molecular Diagnostics Market, by Test Location

9.1.1. Central laboratories

9.1.1.1. Market Revenue and Forecast

9.1.2. Point of care

9.1.2.1. Market Revenue and Forecast

9.1.3. Over the counter or self-test kits

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Molecular Diagnostics Market, By Technology 

10.1. Molecular Diagnostics Market, by Technology

10.1.1. Polymerase Chain Reaction (PCR)

10.1.1.1. Market Revenue and Forecast

10.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)

10.1.2.1. Market Revenue and Forecast

10.1.3. DNA Sequencing & Next- generation Sequencing (NGS)

10.1.3.1. Market Revenue and Forecast

10.1.4. In Situ Hybridization (ISH)

10.1.4.1. Market Revenue and Forecast

10.1.5. DNA Microarrays

10.1.5.1. Market Revenue and Forecast

10.1.6. Others

10.1.6.1. Market Revenue and Forecast

Chapter 11. Global Molecular Diagnostics Market, By Application

11.1. Molecular Diagnostics Market, by Application

11.1.1. Infectious diseases

11.1.1.1. Market Revenue and Forecast

11.1.2. Oncology

11.1.2.1. Market Revenue and Forecast

11.1.3. Genetic testing

11.1.3.1. Market Revenue and Forecast

11.1.4. Neurological disease

11.1.4.1. Market Revenue and Forecast

11.1.5. Microbiology

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Molecular Diagnostics Market, By End User

12.1. Molecular Diagnostics Market, by End User

12.1.1. Diagnostic Laboratories

12.1.1.1. Market Revenue and Forecast

12.1.2. Hospitals & Clinics

12.1.2.1. Market Revenue and Forecast

12.1.3. Others

12.1.3.1. Market Revenue and Forecast

Chapter 13. Global Molecular Diagnostics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product

13.1.2. Market Revenue and Forecast, by Test Location

13.1.3. Market Revenue and Forecast, by Technology

13.1.4. Market Revenue and Forecast, by Application

13.1.5. Market Revenue and Forecast, by End User

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product

13.1.6.2. Market Revenue and Forecast, by Test Location

13.1.6.3. Market Revenue and Forecast, by Technology

13.1.6.4. Market Revenue and Forecast, by Application

13.1.6.5. Market Revenue and Forecast, by End User  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product

13.1.7.2. Market Revenue and Forecast, by Test Location

13.1.7.3. Market Revenue and Forecast, by Technology

13.1.7.4. Market Revenue and Forecast, by Application

13.1.7.5. Market Revenue and Forecast, by End User

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product

13.2.2. Market Revenue and Forecast, by Test Location

13.2.3. Market Revenue and Forecast, by Technology

13.2.4. Market Revenue and Forecast, by Application  

13.2.5. Market Revenue and Forecast, by End User  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product

13.2.6.2. Market Revenue and Forecast, by Test Location

13.2.6.3. Market Revenue and Forecast, by Technology

13.2.7. Market Revenue and Forecast, by Application  

13.2.8. Market Revenue and Forecast, by End User  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product

13.2.9.2. Market Revenue and Forecast, by Test Location

13.2.9.3. Market Revenue and Forecast, by Technology

13.2.10. Market Revenue and Forecast, by Application

13.2.11. Market Revenue and Forecast, by End User

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product

13.2.12.2. Market Revenue and Forecast, by Test Location

13.2.12.3. Market Revenue and Forecast, by Technology

13.2.12.4. Market Revenue and Forecast, by Application

13.2.13. Market Revenue and Forecast, by End User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product

13.2.14.2. Market Revenue and Forecast, by Test Location

13.2.14.3. Market Revenue and Forecast, by Technology

13.2.14.4. Market Revenue and Forecast, by Application

13.2.15. Market Revenue and Forecast, by End User

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product

13.3.2. Market Revenue and Forecast, by Test Location

13.3.3. Market Revenue and Forecast, by Technology

13.3.4. Market Revenue and Forecast, by Application

13.3.5. Market Revenue and Forecast, by End User

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product

13.3.6.2. Market Revenue and Forecast, by Test Location

13.3.6.3. Market Revenue and Forecast, by Technology

13.3.6.4. Market Revenue and Forecast, by Application

13.3.7. Market Revenue and Forecast, by End User

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product

13.3.8.2. Market Revenue and Forecast, by Test Location

13.3.8.3. Market Revenue and Forecast, by Technology

13.3.8.4. Market Revenue and Forecast, by Application

13.3.9. Market Revenue and Forecast, by End User

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product

13.3.10.2. Market Revenue and Forecast, by Test Location

13.3.10.3. Market Revenue and Forecast, by Technology

13.3.10.4. Market Revenue and Forecast, by Application

13.3.10.5. Market Revenue and Forecast, by End User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product

13.3.11.2. Market Revenue and Forecast, by Test Location

13.3.11.3. Market Revenue and Forecast, by Technology

13.3.11.4. Market Revenue and Forecast, by Application

13.3.11.5. Market Revenue and Forecast, by End User

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product

13.4.2. Market Revenue and Forecast, by Test Location

13.4.3. Market Revenue and Forecast, by Technology

13.4.4. Market Revenue and Forecast, by Application

13.4.5. Market Revenue and Forecast, by End User

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product

13.4.6.2. Market Revenue and Forecast, by Test Location

13.4.6.3. Market Revenue and Forecast, by Technology

13.4.6.4. Market Revenue and Forecast, by Application

13.4.7. Market Revenue and Forecast, by End User

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product

13.4.8.2. Market Revenue and Forecast, by Test Location

13.4.8.3. Market Revenue and Forecast, by Technology

13.4.8.4. Market Revenue and Forecast, by Application

13.4.9. Market Revenue and Forecast, by End User

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product

13.4.10.2. Market Revenue and Forecast, by Test Location

13.4.10.3. Market Revenue and Forecast, by Technology

13.4.10.4. Market Revenue and Forecast, by Application

13.4.10.5. Market Revenue and Forecast, by End User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product

13.4.11.2. Market Revenue and Forecast, by Test Location

13.4.11.3. Market Revenue and Forecast, by Technology

13.4.11.4. Market Revenue and Forecast, by Application

13.4.11.5. Market Revenue and Forecast, by End User

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product

13.5.2. Market Revenue and Forecast, by Test Location

13.5.3. Market Revenue and Forecast, by Technology

13.5.4. Market Revenue and Forecast, by Application

13.5.5. Market Revenue and Forecast, by End User

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product

13.5.6.2. Market Revenue and Forecast, by Test Location

13.5.6.3. Market Revenue and Forecast, by Technology

13.5.6.4. Market Revenue and Forecast, by Application

13.5.7. Market Revenue and Forecast, by End User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product

13.5.8.2. Market Revenue and Forecast, by Test Location

13.5.8.3. Market Revenue and Forecast, by Technology

13.5.8.4. Market Revenue and Forecast, by Application

13.5.8.5. Market Revenue and Forecast, by End User

Chapter 14. Company Profiles

14.1. Siemens Healthineers AG (Germany)

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Quidel Corporation (US)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. F. Hoffmann-La Roche Ltd. (Switzerland)

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Hologic, Inc. (US)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Thermo Fisher Scientific, Inc. (US)

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Danaher Corporation (US)

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Illumina, Inc. (US)

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Becton, Dickinson and Company (US)

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Grifols, S.A. (Spain)

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. PerkinElmer, Inc. (US)

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global molecular diagnostics market size was accounted at USD 43.68 billion in 2024 and it is expected to reach around USD 63.86 billion by 2034.

The global molecular diagnostics market is poised to grow at a CAGR of 3.87% from 2025 to 2034.

The major players operating in the molecular diagnostics market are Siemens Healthineers AG, Quidel Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Illumina, Inc., Becton, Dickinson and Company, Grifols, S.A., PerkinElmer, Inc., Abbott Laboratories, bioMérieux SA, QIAGEN N.V., Myriad Genetics, Inc., Agilent Technologies, Inc., geneOmbio Technologies Pvt. Ltd.

Increase in the attracting numerous diseases, increase in various other diseases like HIV, HPV and STI and increase in the geriatric population these are driving the growth of the molecular diagnostics market.

North America will lead the global molecular diagnostics market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client